School of Medicine
Showing 501-600 of 612 Results
-
Allison Tamara Siebern
Adjunct Clinical Associate Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioDr. Allison Siebern, PhD, DAc, LAc, CBSM is a sleep medicine psychologist and neuroscience-based doctor of acupuncture specializing in sleep, mood, and neurological health. She is board certified in Behavioral Sleep Medicine by the American Board of Sleep Medicine.
Dr. Siebern is a pioneer in the field of integrative sleep health as she blends her training and expertise in neuroscience-based acupuncture, cognitive behavioral medicine, psychophysiology, near-infrared transcranial photobiomodulation and clinical neuroscience. Dr. Siebern's current integrative health research is on the intersection of scalp acupuncture and near-infrared transcranial photobiomodulation (tPBM) as neuromodulatory mechanisms to assist in improved symptom outcomes in neurodegenerative disorders and post-stroke recovery.
Dr. Siebern is currently a Sleep Medicine Psychologist and Behavioral Sleep Medicine Fellowship Track Director with the Durham VA Medical Center and the Director of Integrative Sleep Wake Health, PLLC. Dr. Siebern is an Adjunct Clinical Associate Professor at Stanford University School of Medicine in the Sleep Medicine Division where she completed the sleep fellowship from 2008 to 2010 and stayed on as full-time faculty until 2015 where she served as Associate Director and Co-Fellowship Training Director and then Director of the Behavioral Sleep Medicine Program. She has been treating patients of all ages in the field of sleep medicine for 15 years. She consults with companies on sleep and neurological health science, is published in peer-reviewed journals, has given talks at national conferences, and has been interviewed with many media outlets. Dr. Siebern has a passion for the field of sleep health and believes in the importance of training future generations of sleep providers. -
David Smith, M.D.
Academic Staff - Hourly - CSL, Psychiatry and Behavioral Sciences
BioDr. Smith is a psychiatrist and clinical psychopharmacologist in private practice in Palo Alto, CA, and an Adjunct Professor in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. He majored in both biological science and English literature at Cornell University, received his M.D. from UCLA, and completed his psychiatry residency and NIMH research fellowship at Stanford University School of Medicine and Hospital.
Dr. Smith is currently co-director of the pre-clerkship curriculum in psychiatry at the Stanford medical school. -
Ethan Solomon
Instructor, Psychiatry and Behavioral Sciences
BioDr. Solomon is an Instructor in the Department and Psychiatry and Behavioral Sciences and a member of the Stanford Precision Neurotherapeutics Lab. He earned his MD and PhD in Bioengineering through the Medical Scientist Training Program at the University of Pennsylvania, and completed residency training in psychiatry at the Stanford School of Medicine. His research focuses on electrophysiological techniques (stereo-EEG/ECoG, scalp EEG) and brain stimulation technologies (direct electrical stimulation, deep brain stimulation, and transcranial magnetic stimulation) to understand cognitive and perceptual processes in psychiatric illness. Dr. Solomon is a recipient of an NIMH K99 grant to study the use of theta burst stimulation in hippocampal-cortical networks of patients with schizophrenia.
-
Natalie Solomon
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Solomon is a licensed psychologist, board certified in behavioral sleep medicine, and a clinical associate professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. Dr. Solomon conducts research as a member of the Computational Psychiatry, Neuroimaging, Sleep Lab (CoPsyN Sleep Lab) and treats patients in the Sleep Health and Insomnia Program (SHIP). Dr. Solomon specializes in the study and treatment of sleep disorders. Her clinical interests include the intersection of sleep difficulties with overall quality of life and women’s health. Dr. Solomon enjoys treating a variety of sleep difficulties, including insomnia, hypnotic dependence, circadian rhythm disturbances, NREM parasomnias, and nightmares. Dr. Solomon additionally consults, teaches undergrads, graduate students, and continuing studies, supervises postdoctoral fellows, and trains providers to deliver insomnia treatment.
-
Barbara Sommer
Associate Professor of Psychiatry and Behavioral Sciences at the Stanford University Medical Center, Emerita
Current Research and Scholarly InterestsI am interested in the clinical investigation of cognitive stresses during younger adulthood that may give rise to frank intellectual impairment with older age. Examples may include specific kinds of chronically taken medications.
-
David Spiegel
Jack, Lulu and Sam Willson Professor of Medicine
On Partial Leave from 10/01/2025 To 05/15/2026Current Research and Scholarly InterestsDr. Spiegel's research program involves mind/body interactions, including cancer progression, the response to traumatic stress, and the effect of hypnosis on the perception of pain and anxiety.
-
Nicole Starace
Adjunct Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Nicole Starace received her undergraduate degree from the University of Pennsylvania, where she worked in the lab of Dr. Aaron T. Beck, the founder of Cognitive Behavioral Therapy (CBT). Her work at Penn sparked her interest in the growing field of Evidence-Based Psychotherapy. She received her MA and PhD in Clinical Psychology from UCLA, where she trained under Dr. Bruce Chorpita and conducted research in the field of Dissemination and Implementation of Evidence-Based Psychotherapy. Dr. Starace joined the faculty at Stanford in 2015 where she held appointments as a Clinical Instructor and a Clinical Assistant Professor. She continued to champion evidence based practices in her leadership roles and as a clinical supervisor for trainees in the Department of Psychiatry and Behavioral Sciences, Division of Child and Adolescent Psychiatry. Dr. Starace left Stanford in 2022 when she relocated back the East Coast, but she returned to Stanford as an Adjunct Clinical Assistant Professor in 2023. Dr. Starace specializes in the treatment of OCD, Anxiety, and Tic Disorders and Parenting for youth with disruptive behavior challenges and anxiety. She works with children, teens, and adults.
-
Maria-Christina Stewart
Adjunct Clinical Instructor, Psychiatry and Behavioral Sciences
BioDr. Stewart specializes in the prevention and treatment of eating, obsessive-compulsive, anxiety, and depressive disorders - and the intersection between them. At Stanford she lectures on evidence-based eating disorder treatments for children and adolescents. Dr. Stewart also runs a private practice, writes, consults, lectures, and hosts the 'Meaning Vs Merit' podcast - exploring how to find meaning in our achievement and merit-focused culture.
-
Eric Stice
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
BioDr. Stice served as an assistant professor and associate professor at the University of Texas at Austin and as a Senior Research Scientist at Oregon Research Institute before joining the faculty at Stanford University. His research focuses on identifying risk factors that predict onset of eating disorders, obesity, substance abuse, and depression to advance knowledge regarding etiologic processes, including the use of functional neural imaging. He also designs, evaluates, and disseminates prevention and treatment interventions for eating disorders, obesity, and depression. For instance, he developed a dissonance-based eating disorder prevention program that has been implemented with over 6 million young girls in 140 countries. He has published 335 articles in high-impact outlets, including Science, Psychological Bulletin, Archives of General Biological Psychiatry, American Journal of Clinical Nutrition, and Journal of Neuroscience.
-
Thomas Sudhof
Avram Goldstein Professor in the School of Medicine, Professor of Neurosurgery and, by courtesy, of Neurology and Neurological Sciences and of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsInformation transfer at synapses mediates information processing in brain, and is impaired in many brain diseases. Thomas Südhof is interested in how synapses are formed, how presynaptic terminals release neurotransmitters at synapses, and how synapses become dysfunctional in diseases such as autism or Alzheimer's disease. To address these questions, Südhof's laboratory employs approaches ranging from biophysical studies to the electrophysiological and behavioral analyses of mutant mice.
-
Mariella Suleiman, MD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
BioDr. Mariella Suleiman is a board-certified, fellowship-trained psychiatrist with Stanford Health Care. She is also a clinical assistant professor in the Department of Psychiatry and Behavioral Sciences, Division of Medical Psychiatry at Stanford University School of Medicine.
Dr. Suleiman has special training in treating women's reproductive mental health conditions across the lifespan, including but not limited to perinatal mood and anxiety disorders (PMADs), premenstrual dysphoric disorder (PMDD), and perimenopausal disorders. She also specializes in psychosomatic medicine, which focuses on appropriate psychological care for a range of reactions to illness. At Stanford Medicine, she works with the Consultation-Liaison Psychiatry Service, which provides treatment recommendations to manage psychiatric conditions while patients are hospitalized.
Dr. Suleiman’s research interests span advocacy to improve regulation of medications to treat mania in bipolar disorder (valproate) in the childbearing years, clinical approaches to treating agitation during pregnancy, and evidence-based management of bipolar disorder during and after pregnancy.
Dr. Suleiman has published her research in peer-reviewed journals such as The Journal of Clinical Psychiatry, Academic Psychiatry, The Primary Care Companion for CNS Disorders, and CNS Drugs. She has presented to her peers at international, national, and regional meetings, including those of the Academy of Consultation-Liaison Psychiatry (ACLP), the American Association for Directors of Psychiatric Residency Training (AADPRT), and the Royal Health Awareness Society (RHAS) of Jordan.
Dr. Suleiman is a member of the ACLP, the American Psychiatric Association (APA), the Jordan Medical Association (JMA), and the Northern California Psychiatric Society (NCPS). -
Edith Vioni Sullivan
Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator)
Current Research and Scholarly InterestsApplication of neuroimaging modalities and component process analysis of cognitive, sensory, and motor functions to identify brain structural and functional mechanisms disrupted in diseases affecting the brain: alcohol use disorder, HIV infection, dementia, and normal aging from adolescence to senescence.
-
Trisha Suppes, MD, PhD
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsLong-term treatment strategies for bipolar disorder, treatment for bipolar II disorder, use of treatment algorithms, and treatment of major depression.
-
Miranda Tan, DO
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioDr. Tan is a board-certified sleep medicine physician with the Sleep Medicine Center at Stanford Health Care. She is also a clinical associate professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine.
Dr. Tan specializes in diagnosing and treating common and rare sleep disorders. Her multidisciplinary approach to care is focused on improving patients’ quality of life and long-term health. Dr. Tan is fellowship-trained and board-certified in sleep medicine, pulmonary medicine, and critical care medicine.
Some of Dr. Tan’s research has focused on improving the understanding of fatigue and sleep disorders in cancer patients and survivors. Her work has also highlighted the positive potential of artificial intelligence and machine learning to enhance diagnostic methods for sleep disorders.
Dr. Tan has published her work in numerous prestigious peer-reviewed journals, including the American Journal of Respiratory and Critical Care Medicine, Chest, and the Journal of Clinical Sleep Medicine. She has also been an invited guest speaker and moderator at national meetings, including those for the American College of Chest Physicians and the American Academy of Sleep Medicine.
Dr. Tan is a fellow of the American College of Chest Physicians and a member of the American Academy of Sleep Medicine and the American Thoracic Society. -
Steven Tate
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Steven Tate serves as a Clinical Assistant Professor specializing in addiction medicine within the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. He earned his medical degree from the University of Chicago and his master's in medical statistics from the London School of Hygiene and Tropic Medicine. He then completed his internal medicine residency at the University of Pennsylvania and his fellowship in addiction medicine at Stanford. Dr. Tate sees patients in the Stanford Addiction Medicine/Dual Diagnosis Clinic and in the hospital on the Inpatient Addiction Medicine Consult Service. He is interested in teaching evidence-based addiction medicine and translating evidence into practice to improve the care of patients with substance use disorders.
-
Pahnwat Tonya Taweesedt, MD
Clinical Instructor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioDr. Pahnwat Taweesedt is a board-certified, fellowship-trained sleep specialist at Stanford Health Care. She is also a clinical instructor in the Department of Psychiatry and Behavioral Sciences, Division of Sleep Medicine at Stanford University School of Medicine.
Dr. Taweesedt specializes in diagnosing and treating sleep disorders such as obstructive sleep apnea (OSA) and central sleep apnea (CSA). She also treats obesity hypoventilation syndrome, a condition that causes breathing issues during sleep.
Her research focuses on sleep technology, the relationship between sleep and neurodevelopmental disorders, and sleep in the aging population. She has also studied medications for narcolepsy (a disorder that affects the brain’s ability to control sleep-wake cycles).
Dr. Taweesedt has contributed chapters to a variety of medical textbooks, including “Advances in Health and Disease” and “Vasculitis: From Diagnosis to Treatment.” She also serves as a reviewer for several peer-reviewed research journals, including Sleep Science and Practice, Healthcare, and Journal of Autism and Developmental Disorders.
Dr. Taweesedt is a member of the American College of Chest Physicians, American Thoracic Society, Sleep Tracker Task Force of World Sleep Society, and American Academy of Sleep Medicine. -
Allison L. Thompson, Ph.D.
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Allison Thompson specializes in the treatment of Post-Traumatic Stress Disorder, anxiety and depression, and severe mental illness. She has practiced at Stanford since 2008. She has a special interest in the treatment of underrepresented and underserved populations, such as people of color.
-
Dolores Gallagher Thompson, PhD, ABPP
Professor (Research) of Psychiatry and Behavioral Science (Public Mental Health and Population Sciences), Emerita
Current Research and Scholarly InterestsMy current research focuses on use of technology to improve mental health of older persons and their family members. I have a strong interest in how cultural diversity impacts mental health access, services, and outcomes. I am currently involved in several international research and demonstration projects in collaboration with the World Health Organization and the health care system in Thailand as well as projects in the US - notably, with rural caregivers and those of Asian American ancestry.
-
Jamie L. Tingey, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
Current Research and Scholarly InterestsDr. Tingey’s research broadly focuses on factors that promote positive outcomes in patients with complex and/or chronic conditions. She is committed to research that focuses on outcomes that are valued by patients and healthcare stakeholders.
Some of her research interests include self-management interventions in chronic conditions (e.g., multiple sclerosis, stroke, spinal cord injury, traumatic brain injury) and adapting evidence-based treatments to provide equitable care to individuals with chronic conditions and disabilities. She is also passionate about integrating psychology services into critical care settings to improve health outcomes among ICU survivors. -
Julie Tinklenberg
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Vaden Health Center
BioDr. Julie Tinklenberg specializes in the treatment of mental illness in the university setting. She has worked in college mental health for over 15 years. Dr.Tinklenberg has a special interest in anxiety disorders, parenting issues, mood disorders and interpersonal/relationship problems.
-
Hui Qi Tong
Clinical Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
BioClinical Professor, Stanford Department of Psychiatry & Behavioral Sciences
Clinical Associate Professor, Stanford Department of Psychiatry & Behavioral Sciences
HS Clinical Assistant Professor, UCSF Department of Psychiatry & San Francisco VA Health Care
Staff Psychologist: Women's Mental Health Program, San Francisco VA Health Care System
Academic visitor: Oxford Mindfulness Center, Department of Psychiatry, Oxford University
Psychology Post-doctoral Fellowship: UCSF/San Francisco VA Health Care System
Psychology Pre-doctoral Internship: UCSF/San Francisco VA Health Care System
Psychology Education: Pacific Graduate School of Psychology, Palo Alto University (2008)
Clinical Research Associate: Department of Psychiatry, Tufts University School of Medicine
Research Fellow: Genetics Division, Department of Medicine, Boston Children's Hospital,Harvard Medical School
Medical Education: Fudan University, Shanghai Medical College, Shanghai, China (1994) -
Lénie Torregrossa, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Lénie Torregrossa is a clinical psychologist and Clinical Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the Stanford University School of Medicine. At Stanford, she works on the inpatient psychiatric units and the INSPIRE clinic. Dr. Torregrossa was previously a research psychologist in the brain imaging and EEG lab at the University of San Francisco (UCSF).
She specializes in schizophrenia spectrum disorders, psychosis, and serious mental illness. Her approach to treatment is person centered and recovery focused, grounded in cognitive behavioral therapy (CBT) and informed by acceptance and commitment therapy (ACT). She emphasizes collaboration, values-based living, and meaningful functional goals.
Dr. Torregrossa's research focuses on risk and protective factors for schizophrenia-spectrum disorders, self-disturbances in schizophrenia, and improving treatments for psychosis.
She has published articles in many peer-reviewed journals, including JAMA Network Open, Schizophrenia Bulletin, Schizophrenia Research, and Frontiers in Psychiatry. She has presented to her peers at international, national, and regional meetings, including the European Conference on Schizophrenia Research, the International Consortium for Schizotypy Research, the Congress of the Schizophrenia International Research Society, and the Annual Meeting of the Society for Research in Psychopathology.
Dr. Torregrossa is a member of the Schizophrenia International Research Society, the Society of Biological Psychiatry, the American Psychological Association, and the North America CBT for Psychosis Network. -
Jacob Towery
Adjunct Clinical Instructor, Psychiatry and Behavioral Sciences
BioJacob Towery, MD is an adolescent and adult psychiatrist in private practice in Palo Alto, California. He attended Duke University for his undergraduate studies, University of Virginia for medical school, and Stanford for his residency in adult psychiatry and fellowship in adolescent psychiatry. He is the author of "The Anti-Depressant Book," available on Amazon. He currently serves on the Adjunct Faculty at Stanford University School of Medicine. He enjoys seeing patients, snowboarding, scuba diving, traveling, reading fantasy novels, meditating, spending quality time with other humans, making gratuitously long lists, and writing about himself in the third person. More information can be found at www.jacobtowerymd.com
-
Ranak Trivedi
Associate Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsEnhancing the role of informal caregivers in chronic disease self-management; assessment and treatment of mental illness in primary care settings; psychosocial antecedents and consequences of cardiovascular disease.
-
Mickey Trockel
Professor of Psychiatry and Behavioral Sciences
BioMickey Trockel is the Director of Evidence Based Innovation for the Stanford University School of Medicine WellMD Center. His development of novel measurement tools has led to growing focus on professional fulfillment as a foundational aim of efforts to promote physician well-being. His scholarship also identifies interpersonal interactions at work as a modifiable core determinate of an organizational culture that cultivates wellness.
Dr. Trockel serves as the chair of the Physician Wellness Academic Consortium Scientific Board, which is a group of academic medical centers working together to improve physician wellbeing. The consortium sites have adopted the physician wellness assessment system Dr. Trockel and his colleagues have developed, which offers longitudinal data for benchmarking and natural experiment based program evaluation. His previous research included focus on college student health, and evaluation of the efficacy of a national evidence based psychotherapy dissemination effort. His more recent scholarship has focused on physician wellbeing. He is particularly interested in developing and demonstrating the efficacy of interventions designed to promote wellbeing by improving social culture determinants of wellbeing across student groups, employee work teams, or larger organizations. -
Yuri Tsutsumi
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsClinical Psychology
-
Jason Tucciarone, MD, PhD
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
BioJason Tucciarone MD, PhD is an Assistant Professor with Stanford School of Medicine’s Department of Psychiatry and Behavioral Sciences. As a neuroscientist, he leads a lab interested in biological mechanisms of mental illness and investigating new therapies for mood disorders and addiction. In particular, he is defining new cell types and evolutionary conserved circuits in emotional processing centers of the brain, with the hope of finding new entry points for novel therapeutics. Working with Dr Robert Malenka, he is using optogenetic, chemogenetic, neuroimaging and behavioral approaches in mouse models of addiction to uncover vulnerable brain circuitry in opioid use disorder. Alongside Dr Alan Schatzberg, he is investigating the efficacy of buprenorphine augmentation to IV ketamine infusion at reducing suicidality in treatment resistant depression.
Clinically, he works collaboratively in the department’s Neuropsychiatry clinic and his clinical focus includes treating patients with diverse and complex presentations at the interface of psychiatry and neurology with particular interest in functional neurological disorders. He sees a small cohort of psychotherapy patients in Individual Psychotherapy Clinic. He also works weekend shifts on Stanford’s inpatient psychiatry units.
Prior to training in psychiatry at Stanford’s research residency track Jason received his bachelor’s degree in biology and philosophy from Union College. He spent three years as a Post-Baccalaureate IRTA fellow at the National Institute of Neurological Disorders and Stroke investigating and developing MRI reportable contrast agents to map neuronal connectivity. Following this he entered the Medical Scientist Training Program (MD/PhD) at the State University of NY Stony Brook University. There he completed a doctoral dissertation in neuroscience under the mentorship Dr. Josh Huang at Cold Spring Harbor Laboratory. His thesis work employed mouse genetic dissections of excitatory and inhibitory cortical circuits with a focus on the circuitry of chandelier inhibitory interneurons in prefrontal cortex.
In addition to his research and clinical work, Jason is passionate about teaching, mentorship, and resident clinical supervision. He joined a working group early in his clinical residency to restructure trainee’s neuroscience education. He teaches introductory lectures in the neuroscience of addiction, PTSD, psychosis, and mood disorders. He also leads resident group supervision in their introductory psychodynamic psychotherapy clinical experience. He supervises medical students, residents, and clinical fellows in Neuropsychiatry clinic. Finally, committed to the Stanford clinical community, he leads a support group for Internal Medicine interns and residents. -
Mirko Uljarevic
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioI am a medically trained researcher focused academic with a background in developmental psychopathology, psychometrics and big data science. My research takes a life-span perspective and is driven by the urgent need to improve outcomes for people with autism and other neuropsychiatric (NPD) disorders and neurodevelopmental conditions (NDD). My primary research interest has focused on combining cutting-edge psychometric procedures and a big data approach to better understand structure of clinical phenotypes across autism and other NPD and NDD and on using this knowledge to improve existing and develop new clinical assessments that are more effective for screening and diagnosis, tracking the natural and treatment-related symptom progression and for use in genetic and neurobiological studies. In addition to my focus on the development of outcome measures, I have collaborated with leading psychopathology researchers and groups in the United States, Europe and Australia on numerous projects spanning a range of topics including genetics, treatment and employment, with a particular focus on understanding risk and resilience factors underpinning poor mental health outcomes in adolescents and adults. Most recently, through several competitively funded projects, I have led the statistical analyses to uncover the latent structure of social and communication and restricted and repetitive behaviors (RRB) clinical phenotypes across NPD and NDD. These findings have enabled us to (i) start capturing and characterizing a highly variable social functioning phenotype across a range of disorders and understanding mechanisms underpinning this variability, (ii) combine phenotypic and genetic units of analyses to advance our understanding of the genetic architecture of RRB, and (iii) focus on identification and characterization of subgroups of individuals that share distinct symptom profiles and demonstrate clinical utility and neurobiological validity. Importantly, this work has provided key information for developing a programmatic line of research aimed at developing novel, comprehensive assessment protocols that combine parent and clinician reports, objective functioning indicators and incorporate state-of-the-art psychometric, mobile and connected technologies and procedures.
I am a co-director of the recently established Program for Psychometrics and Measurement-Based Care (https://med.stanford.edu/sppmc.html) that aims to bring together world-leading expertise in clinical science, psychometrics, and big data analytics to bridge the gap between the science of measurement development and clinical practice and bring improvements to both clinical care and research. -
Alexander Eckehart Urban
Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator) and of Genetics
Current Research and Scholarly InterestsComplex behavioral and neuropsychiatric phenotypes often have a strong genetic component. This genetic component is often extremely complex and difficult to dissect. The current revolution in genome technology means that we can avail ourselves to tools that make it possible for the first time to begin understanding the complex genetic and epigenetic interactions at the basis of the human mind.
-
Keara E. Valentine
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioKeara E. Valentine, Psy.D., is a clinical assistant professor at Stanford University School of Medicine in the Psychosocial Treatment Clinic and OCD Clinic, where she specializes in the assessment and treatment of OCD and related disorders. Dr. Valentine utilizes behavioral-based therapies including Cognitive Behavioral Therapy (CBT) and Exposure and Response Prevention (ERP) with children, adolescents, and adults experiencing anxiety-related disorders.
Dr. Valentine completed an APA accredited pre-doctoral internship at Alexian Brothers Behavioral Health Hospital, where she complete a rotation in OCD and anxiety disorders and a rotation in Eating Disorders. Dr. Valentine has experience working with individuals with OCD, anxiety, and/or eating disorders at various levels of care including outpatient, partial hospitalization, residential, and inpatient. -
Axel Valle, PsyD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Axel Valle is a licensed clinical psychologist providing individual psychotherapy in English and Spanish. He specializes in cognitive behavioral therapy (CBT) for obsessive-compulsive disorder (OCD) and anxiety disorders, with additional expertise in working with high-performance athletes.
Dr. Valle brings a distinctive international clinical background to his practice. He completed his postdoctoral fellowship at Stanford University School of Medicine’s Department of Psychiatry and Behavioral Sciences and earned his doctorate in clinical psychology from The Wright Institute in Berkeley. He also holds a Master’s degree in crisis and trauma from Tel Aviv University and is a licensed clinical psychologist in Mexico City, his place of origin. -
Peter Johannes van Roessel
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Peter van Roessel, MD, PhD, completed his MD at Stanford University and his residency training in psychiatry at Columbia University and the New York-Presbyterian Hospital in New York City, with additional training in psychodynamic psychotherapy via the Columbia University Center for Psychoanalytic Training and Research. Prior to joining the clinical faculty at Stanford, he worked for several years as Associate Director of the general research unit of the New York State Psychiatric Institute, a premier state-funded research hospital affiliated with Columbia University.
At Stanford, Dr. van Roessel sees adult mood and anxiety disorders outpatients through the Assessment and Psychodynamic Psychotherapy Clinics and participates in resident training and patient care as director of the resident Continuity Clinic and as a supervisor in psychodynamic psychotherapy. He additionally directs the third-year resident curriculum in psychopathology and psychopharmacology and co-leads a new adult outpatient ketamine-assisted psychotherapy clinic.
As Director of Clinical Research for the department's Rodriguez Translational Therapeutics Lab, he sees individuals with obsessive-compulsive spectrum disorders for evaluations and research-protocol driven clinical treatment and leads clinical neuroscience studies pioneering rapid-acting interventions in OCD. Clinically motivated research interests include the nature and neural correlates of metacognitive awareness ('insight') in OCD and related disorders, and particularly the relationship of awareness to mechanisms of attentional control and the processing of incongruity and error. Dr. van Roessel additionally contributes as co-investigator to the Suppes Exploratory Therapeutics Laboratory and to the Williams PANLab, on clinical trials advancing psychedelic-assisted psychotherapies and biomarker-informed precision medicine in depression and posttraumatic stress disorder.
Dr. van Roessel pursued research training in basic neuroscience prior to his clinical training, completing an MPhil in Biology via the Open University, UK, for research performed at the Max Planck Institute for Developmental Biology in Tübingen Germany, and a PhD in molecular and developmental neurobiology at the University of Cambridge, UK. He has contributed to work in the lab of Dr Julia Kaltschmidt (Stanford) on studies of GABAergic/Glutamatergic interneuronal circuity in mouse. He received a 2018 NARSAD Young Investigator Award to pursue study of nitrous oxide as a rapid-acting treatment for OCD, he was a 2020-2022 Miller Foundation Fellow, and from 2020 to 2022 was a Advanced Fellow in Mental Illness Treatment and Research via the Sierra Pacific Mental Illness Research, Education, and Clinical Center of the Palo Alto VA. Dr. van Roessel is a Fellow of the American Psychiatric Association and a member of the American College of Psychiatrists. -
Nina Vasan, MD, MBA
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsAt Brainstorm: The Stanford Lab for Mental Health Innovation, we lead the way in digital well-being: translating cutting-edge research into practical solutions for healthier tech use.
We are first and foremost practicing physicians; we treat patients and families. Then, grounded by the foundational oath in medicine to “do no harm,” we help companies build products that prioritize user health with responsibility and care. Our work has shaped platforms used by millions—helping Pinterest design "compassionate search", guiding TikTok in healthy screen-time management, and partnering with ML Commons to establish the first mental health safety benchmarks for large language models (LLMs).
Brainstorm is further committed to “do good” by leveraging these technologies to build a healthier digital world. We advised Dove’s Self-Esteem Project and Real Beauty Prompt Playbook, which studied AI’s impact on beauty and set new digital standards of representation. Additionally, after sharing the results of research conducted with the Stanford Center for AI Safety on the ethics, efficacy, and safety of LLMs providing mental health support, we developed the “Framework for Healthy AI” to guide industry best practices in AI product innovation.
As we apply this expertise to improve users' daily lives, it’s clear that addressing digital intimacy presents unique challenges compared to traditional human relationships. This technology is still emerging, and we are all adapting to it in real-time as it evolves. The big question is: How can we help users cultivate healthy, safe digital relationships?
After seeing success with the Stanford Social Media Safety Plan, which reduced harmful digital behaviors among users, we are now designing the Stanford GenAI Psychological Safety Plan (GPS). The Stanford GPS is a tool to help individuals, tech developers, and policymakers navigate this new terrain and make informed decisions about AI’s role in mental health.
Check out the start of the Stanford GPS in Fortune: This 4-question quiz from Stanford psychiatrists can help protect from the dangers of AI. -
Mytilee Vemuri
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsI am a Clinical Assistant Professor of Psychiatry, with clinical and research interests in hormonal influences on women’s mental and cognitive health. After Psychiatry residency I completed a NIMH research fellowship studying gender differences in metabolic complications such as dyslipidemia, obesity, and insulin-resistance in patients with bipolar disorder. As a research fellow, I also provided clinical oversight for research participants in studies evaluating hormonal change, metabolic biomarkers and mood. More recently, I have collaborated with PI Duncan and her research group on projects studying relationships between sex hormones and mood/anxiety disorders, particularly in peri-menopausal women. From these experiences I have gained experience in conducting clinical research and collaborating in interdisciplinary research teams. I have also had over 20 years of clinical experience as an attending psychiatrist in Stanford Women’s Wellness psychiatry, general psychiatry and primary care clinics treating a wide range of psychiatric conditions including perimenopausal and geriatric mood disorders. I have published review articles detailing the evidence-basis for treating mood disorders in women during times of hormonal change, and the role of hormones as potential treatments. I also serve as the Stanford Psychiatry Department’s clinical quality improvement leader, where I oversee multiple interdisciplinary improvement teams charged with improving the quality and efficiency of care processes. I currently specialize in managing perimenopausal mood disorders and have an interest in the judicious use of menopausal hormone therapy as an adjunctive treatment for mood symptoms in this population. My clinical and research experience in the intersection of women’s mental health, sex-steroid hormones, and the perimenopause, along with broad experience working on cross-disciplinary teams, will bring valuable input to this research team.
-
Teresa Michelle Vente
Clinical Associate Professor, Pediatrics
Clinical Associate Professor (By courtesy), Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child DevelopmentBioTeresa Vente, DO, MPH is a pediatrician, psychiatrist, and palliative care physician at Lucile Packard Children’s Hospital at Stanford. Her clinical and research interests include expanding psychiatry support for pediatric palliative care patients. Her academic interests include curriculum development and medical education for trainees and clinicians at all levels. She is a facilitator for both VitalTalk and EPEC (Education in Palliative and End-of-Life Care) programs nationally and internationally. Prior to coming to Stanford, she was an assistant professor at Ann & Robert H. Lurie Children’s Hospital and Northwestern University where she served as program director for the pediatric and perinatal palliative care fellowship tracks, and most recently she was an assistant professor at Weill Cornell Medicine.
-
Janani Venugopalakrishnan
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Current Research and Scholarly InterestsAutism spectrum disorders
-
Allison Vreeland
Clinical Instructor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Allison Vreeland (she/her) is a licensed clinical psychologist specializing in working with children, teens, and families. Dr. Vreeland received her PhD in Clinical Psychological Science with a minor in Quantitative Studies at Vanderbilt University. She completed her predoctoral clinical internship in Child Psychology at UCSF with specialty training through the Child Trauma Research Program. She completed a research and clinical fellowship in the Immune Behavioral Health Clinic at Stanford University, where she focused her research efforts on examining neurological markers of patients diagnosed with pediatric acute neuropsychiatric syndrome (PANS). Clinically, Dr. Vreeland’s program of clinical care is focused on the delivery of evidence-based clinical interventions for individuals with anxiety, OCD, PANS/PANDAS, mood disorders, and behavioral challenges.
-
Lynn C. Waelde, Ph.D.
Adjunct Clinical Professor, Psychiatry and Behavioral Sciences
BioLynn C. Waelde, Ph.D. is an Adjunct Clinical Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine and Professor Emeritus in the Psychology Department at Palo Alto University. Dr. Waelde’s many collaborative publications address the impacts of traumatic events and ways to use mindfulness and meditation to promote resilience and recovery from stress and trauma. She founded and directed the Inner Resources Center which offered intervention groups and trainings to thousands of participants, clients, and therapists over the past 15 years. Dr. Waelde is the author of Mindfulness and Meditation in Trauma Treatment: The Inner Resources for Stress Program, published in 2022. She has taken a special interest in family caregivers and the Inner Resources for Stress program has been named a Best Practice by the Benjamin Rose Institute on Aging. She recently coauthored Family Caregiver Distress, which is forthcoming in 2023. She is on the editorial board of Journal of Traumatic Stress and an Associate Editor of Mindfulness.
-
Dennis Wall
Professor of Pediatrics (Clinical Informatics), of Biomedical Data Science and, by courtesy, of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsSystems biology for design of clinical solutions that detect and treat disease
-
Gordon Wang
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioGordon Wang received his Bachelors of Arts and Science from the University of California, Davis in 2000 majoring in Comparative literature and Genetics. He received his PhD under Dr. Mu-ming Poo at the University of California, Berkeley in 2005 studying the role of ion channels in mediating neuronal growthcone guidance decisions. As a postdoctoral scholar in the lab of Dr. Stephen Smith at Stanford University, Gordon developed a computational architecture for the detailed study of molecular diversity in synapses and using this system, he studied the diverse role of synaptic diversity in neurodevelopmental diseases, such as fragile x syndrome. In a co-postdoc in Dr. Philippe Mourrain's lab, he studied the dynamic plasticity of synapses in sleep and circadian cycles in larval zebrafish using multi-photon microscopy. The Wang lab focuses on developing imaging tools to deeply analyze proteins, mRNA and lipids at the synapses, and understand how synaptic heterogeneity affect the function of neural circuits throughout development and aging and in diseases such as autism and fragile x syndrome.
-
Po Wang
Clinical Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsBipolar Disorders, Psychopharmacology, Treatment, Anticonvulsants, Mood stabilizers
-
Kathleen Watson
Instructor, Psychiatry and Behavioral Sciences
BioKathleen Watson, Ph.D., currently serves as an instructor at Stanford University School of Medicine, specializing in Epidemiology and Clinical Research. She co-founded Microclinic International in 2007, where she served as Chief Operating Officer until 2012, focusing on socially-based health interventions for underserved communities.
Dr. Watson's research encompasses various aspects of mental health and metabolism. She investigates the connection between insulin resistance and depression, using computational psychiatry to uncover insights into the interplay of metabolic factors in mental well-being. Additionally, her exploration of cognitive aging examines how metabolic alterations might impact cognitive decline and related disorders. Furthermore, her research in proteomics aims to identify potential biomarkers for severe major depressive disorder. Dr. Watson has recently become a part of the Stanford Autism Center for Excellence Data Core, where she works under the guidance of Dr. Booil Jo. -
Aileen Whyte, PhD
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Aileen Whyte, a licensed psychologist in California, brings over two decades of specialized expertise to the treatment of eating disorders in young people. Beyond her clinical practice, Dr. Whyte actively works on implementing strategies to expand the reach of evidence-based treatments for eating disorders, aiming to make these best-practice interventions more accessible to a wider population.
Dr Whyte serves as the Director of the Stanford Outpatient Child & Adolescent Eating Disorders Clinic, where she provides treatment to young people with eating disorders and provides supervision to psychology and psychiatry fellows. Dr Whyte is a certified practitioner and consultant in Family-Based Treatment (FBT) for eating disorders. She serves as a study therapist in NIMH-sponsored randomized clinical trials focused on examining FBT and related adaptations.
In addition to her clinical responsibilities, Dr. Whyte has led multiple seminars, workshops, and training sessions dedicated to the treatment of eating disorders. She provides ongoing training and consultation in FBT, reaching diverse audiences, including multidisciplinary clinicians, psychologists, and psychiatrists, within the US and internationally.
Dr. Whyte earned her PhD in Clinical Psychology from the New School for Social Research in New York. Her research and clinical interests converge on the implementation and dissemination of evidence-based treatments for eating disorders. -
Leanne Williams
Vincent V.C. Woo Professor and Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator)
Current Research and Scholarly InterestsA revolution is under way in psychiatry. We can now understand mental illness as an expression of underlying brain circuit disruptions, shaped by experience and genetics. Our lab is defining precision brain circuit biotypes for depression, anxiety and related disorders. We integrate large amounts of brain imaging, behavioral and clinical data and computational approaches. Biotypes are used in personalized intervention studies with selective drugs, neuromodulation and exploratory therapeutics.
-
Nolan Williams
Professor of Psychiatry and Behavioral Sciences (Major Laboratories & Clinical Translational Neurosciences Incubator)
BioNolan Williams, M.D. is a Professor of Psychiatry and Behavioral Sciences at Stanford University and Director of the Stanford Brain Stimulation Lab. The long-term goals of his research program are to develop innovative technologies and therapeutics capable of modulating the neural circuitry disrupted in mood disorders, OCD, and other neuropsychiatric conditions. His team has been developing neuroimaging-based approaches to precisely target therapeutic delivery and predict treatment responses to therapeutic neuromodulation and psychedelics. Dr. Williams earned his M.D. and completed his dual residencies in neurology and psychiatry at the Medical University of South Carolina (MUSC). Triple board-certified in general neurology, general psychiatry, as well as behavioral neurology and neuropsychiatry, Dr. Williams brings a comprehensive background in clinical neuroscience to his role as a clinically active neuropsychiatrist. His expertise extends to the development and implementation of novel therapeutics, including devices and novel compounds, for central nervous system illnesses.
Over the past decade, Dr. Williams’ laboratory alongside collaborators at Stanford University have pioneered multiple novel therapeutic and human neuroscience approaches. Notably, Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) is the world's first non-invasive, rapid-acting neuromodulation approach for treatment-resistant depression. SAINT received FDA Breakthrough Device Designation Status (2021) and FDA Clearance (2022) and is the first psychiatric treatment to be covered by Medicare New Technology Add-On Payment (NTAP). As of April 2024, SAINT has been reimbursed for patients suffering from severe depression within inpatient psychiatric units. The SAINT technology is being deployed both clinically and in research protocols in laboratories and hospitals worldwide. Dr. Williams also has an expertise in psychedelic medicines for neuropsychiatric illness and is the first investigator to conduct mechanistic clinical trials exploring the neurobiological effects of ibogaine.
His research accomplishments have garnered international recognition, earning prestigious awards from the Pritzker Neuropsychiatric Disorders Consortium, One Mind Institute, Wellcome Leap Foundation, International Brain Stimulation Conference, National Institute of Mental Health (Biobehavioral Research Award for Innovative New Scientists), Society of Biological Psychiatry (A. E. Bennett Award), along with multiple awards from the Brain Behavior Research Foundation (most notably the Gerald L. Klerman Award and Colvin Prize). His work has been featured in Scientific American, The New York Times, The Washington Post, USA Today, CBS Sunday Morning, and the TODAY Show. -
Sharon E. Williams PhD
Clinical Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Current Research and Scholarly InterestsDr. Williams work focuses primarily on cognitive and emotional recovery of children who have been medically compromised. With improved medical treatment and increased survival rates comes the need to better understand the challenges that patients face following a life threatening illness or injury. Dr. Williams utilizes neuropsychological assessments to understand the cognitive abilities of children who have been diagnosed with cancer, head injuries, genetic disorders and other medical conditions.
-
Helen Wilson
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Wilson is a licensed clinical psychologist with expertise in the areas of trauma and life stress, women's wellness and sexual dysfunction, and lifestyle psychiatry. She provides clinical services in these areas and is Co-Director of the Lifestyle Psychiatry Clinic focused on holistic interventions incorporating physical activity, nutrition, stress management, sleep, social connection, and avoidance of risk substances. She has is also a 500 hour certified yoga instructor as has developed a group therapy program that integrates principles of yoga to support management of mood and anxiety symptoms. Dr. Wilson has completed federally funded research focused on relationships between childhood trauma and health risk behavior in adolescence and adulthood and is currently engaged in clinical research. Dr. Wilson has authored or co-authored over thirty journal articles and book chapters related to these topics, and she regularly presents her work at local and national conferences. She is lead editor of the 2023 book Facing Campus Sexual Assault and Relationship Violence With Courage: A Guide for Institutions and Clinicians on Prevention, Support, and Healing. She is currently engaged in a collaboration with Stanford Recreation and Wellness to evaluate the benefits of physical wellness and outdoor education courses.
-
Shannon Wiltsey Stirman
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsThe overarching goal of my program of research is to determine how to facilitate access to evidence-based psychosocial interventions (EBPs) in community and public sector mental health settings. Areas of emphasis include training and consultation, treatment fidelity and adaptation, AI and digital mental health interventions, and the identification of strategies that promote sustained implementation of EBPs.
-
Britt Wray
Instructor, Psychiatry and Behavioral Sciences
BioDr. Wray is the Director of CIRCLE at Stanford Psychiatry, a research and action initiative focused on Community-minded Interventions for Resilience, Climate Leadership and Emotional wellbeing in the Stanford School of Medicine. Her research focuses on the mental health impacts of climate change on young people ('emerging adults') and frontline community members, community-minded psychosocial support interventions, and public engagement for improved mental and planetary health. Wray focuses on co-designing and evaluating evidence-based climate distress (climate anxiety/eco-anxiety) interventions with impacted communities and international networks of Integrated Youth Services using a health equity lens, and brings expertise in conceptual models of climate distress, different measurement modalities for climate impact exposures on mental health, community-engaged research, and co-design methods. Previously, Wray was a Human and Planetary Health Postdoctoral Fellow at the Stanford Center for Innovation in Global Health, Stanford Woods Institute for the Environment and London School of Hygiene & Tropical Medicine. She is the author of two books; her latest Generation Dread: Finding Purpose in an Age of Climate Anxiety, is an impassioned generational perspective on how to stay sane amid climate disruption and was a finalist for the 2022 Governor General’s Award. She is the recipient of the 2025 American Climate Leadership Awards (Runner Up), 2023 Canadian Eco-Hero Award and top award winner of the National Academies Eric and Wendy Schmidt Awards for Excellence in Science Communications, given by The National Academies of Sciences, Engineering, and Medicine. Her first book is Rise of the Necrofauna: The Science, Ethics and Risks of De-Extinction (Greystone Books 2017) and was named a "best book of the year" by The New Yorker. Dr Wray holds a PhD in Science Communication from the University of Copenhagen. She has hosted and produced several science radio programs, podcasts and television programs for international broadcasters including the BBC and CBC, and she has spoken at TED and the World Economic Forum. She is the Founder of Unthinkable (unthinkable.substack.com), a newsletter about building courage and taking meaningful action on the far side of climate grief.
-
Yishan Xu, PhD, DBSM, CST
Adjunct Clinical Instructor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioDr. Xu is a licensed clinical psychologist in California, a Board-certified Behavioral Sleep Medicine Specialist, and AASECT Board-Certified Sex Therapist. She currently serves as the chair of the OPEC committee for the Society of Behavioral Sleep Medicine. She completed training at the Stanford Sleep Medicine Center 2017-2019. She has specialized training in the diagnosis and treatment of insomnia, circadian rhythm disorders, parasomnias, nightmares, and adjustment to PAP therapy for sleep apnea.
Dr. Xu grew up in China and received her Ph.D. in Clinical Psychology from the University of Virginia, VA. She has adapted treatment for insomnia for the Chinese population, and translated the book “The Rested Child” into Chinese, which is the first evidence-based book about children and teen’s sleep disorders in China. She is the founder and director of a multicultural group practice in the SF Bay Area: Mind & Body Garden Psychology Inc. She also hosts a podcast "Deep into Sleep" to help bridge the gap between public awareness and knowledge of sleep problems and the science of sleep medicine.
Publications:
Xu, Y., Barwick, F. & Li, C.(2023). Cultural Considerations in Behavioral Sleep Medicine (BSM): Telehealth Group CBT-I for Patients from a Traditional Chinese Medicine (TCM) Hospital (Submitted)
Prislin, R., Davenport, C., Xu, Y., Moreno, R., & Honeycutt, N. (2018). From marginal to mainstream and vice versa: Leaders' evaluation of diversity while in the minority versus majority. Journal of Social Issues, 74 (1), 112-128.
Attin, M., Xu, Y., Lin, C. D., & Lemus, H. (2015). A potential impact of nursing characteristics prior to in-hospital cardiac arrest: a self-reported study. Journal of Clinical Nursing, 24 (23-24), 3736-3738.
Hu, Y., Xu, Y.,& Tornello, S. L. (2015). Stability of Self-Reported Same-Sex and Both-Sex Attraction from Adolescence to Young Adulthood. Archives of sexual behavior, 1- 9.
Xu, Y., & Ocker, B. (2013). Discrepancies in Cross-cultural and cross-generational attitudes toward committed relationships in China and the United States. Family Court Review, 51 (4), 591–604.
Tornello, S. L., Emery, R., Rowen, J., Potter, D., Ocker, B., & Xu, Y. (2013). Overnight custody arrangements, attachment, and adjustment among very young children. Journal of Marriage and Family, 75 (4), 871-885.
Horn, E. E., Xu, Y., Beam, C. R., Turkheimer, E. & Emery, E. (2012). The marriage benefit? A genetically-informed study of selection and causation. Journal of Family Psychology, 27 (1), 30-41.
Prislin, R., Boyle, S. M., Davenport, C., Farley, A., Jacobs, E., Michalak, J., Uehara, K., Zandian, F., & Xu. Y. (2011). On being influenced while trying to persuade: The feedback effect of persuasion outcomes on the persuader. Social Psychological and Personality Science, 2 (1), 51-58.
Li, j., Xu, Y., & li, X. (2009). Correlation between atypical eating disorder and body- esteem of college students. Chinese Journal of Clinical Psychology, 17, 345-347. -
Jerome Yesavage
Jared and Mae Tinklenberg Professor and Professor, by courtesy, of Neurology and Neurological Sciences
Current Research and Scholarly InterestsWe study cognitive processes and aging in our research center. Studies range from molecular biology to neuropsychology of cognitive processes.
-
Audrey Yoon, DDS
Clinical Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioDr. Yoon is a double board-certified sleep specialist with the Stanford Health Care Sleep Medicine Center. She is currently a Clinical Professor in the Division of Sleep Medicine in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine.
She uses her extensive orthodontic experience to diagnose and treat obstructive sleep apnea (OSA) in children and adults. Dr. Yoon specializes in surgical and non-surgical OSA treatments, such as miniscrew-assisted rapid palatal expansion (MARPE), distraction osteogenesis maxillary expansion (DOME), and maxillomandibular advancement (MMA). These procedures restructure the palate, nasal airway, or jaw to improve airflow.
Her research interests include modifying head and face growth to improve sleep-disordered breathing in children and creating customized appliances that help reshape bones in the mouth, jaw, and face over time. She has also studied genetic anatomical factors related to OSA. Dr. Yoon worked with Stanford Medicine researchers to develop a new DOME technique, and she established and proposed a surgery-first approach protocol for MMA. With this approach, doctors surgically reposition the jaw before starting orthodontic treatment. The surgery-first approach can reduce the amount of time patients need to undergo orthodontic treatment.
Dr. Yoon has published in many peer-reviewed journals, including Sleep, Sleep Medicine, the American Journal of Orthodontics and Dentofacial Orthopedics, and the American Academy of Pediatric Dentistry, and she has written numerous book chapters. She has presented to her colleagues all over the nation and the world, including those in Germany, Italy, Australia, Chile, Singapore and China. Her presentations have covered a range of topics, such as the latest techniques in craniofacial (head and face) growth modification.
Dr. Yoon is a founding co-president of the World Dentofacial Sleep Society. She established a dental sleep medicine specialty clinic in the Division of Sleep Medicine at Stanford University School of Medicine. She also established the Dental Sleep Medicine Clinic at the University of the Pacific and is currently a program director of the Pacific Ortho-Dental Sleep Medicine Fellowship Program. Dr. Yoon also serves on the board of directors for the California Sleep Society, Angle Orthodontists, and the Korean Association of Dental Sleep Medicine.
She is a diplomate of the American Board of Orthodontics and the American Board of Dental Sleep Medicine. -
Jong H. Yoon
Professor of Psychiatry and Behavioral Sciences (Public Mental Health & Population Sciences)
Current Research and Scholarly InterestsMy research seeks to discover the brain mechanisms responsible for schizophrenia and to translate this knowledge into the clinic to improve how we diagnose and treat this condition. Towards these ends, our group has been developing cutting-edge neuroimaging tools to identify neurobiological abnormalities and test novel systems-level disease models of psychosis and schizophrenia directly in individuals with these conditions.
We have been particularly interested in the role of neocortical-basal ganglia circuit dysfunction. A working hypothesis is that some of the core symptoms of schizophrenia are attributable to impairments in neocortical function that results in disconnectivity with components of the basal ganglia and dysregulation of their activity. The Yoon Lab has developed new high-resolution functional magnetic resonance imaging methods to more precisely measure the function of basal ganglia components, which given their small size and location deep within the brain has been challenging. This includes ways to measure the activity of nuclei that store and control the release of dopamine throughout the brain, a neurochemical that is one of the most important factors in the production of psychosis in schizophrenia and other neuropsychiatric conditions.
